Horizon Surgical Systems Secures $30 Million in Funding
Horizon Surgical Systems Secures $30 Million in Funding
Horizon Surgical Systems, Inc., a pioneering micro-robotics company, has made waves in the medical technology field by successfully closing a major round of financing. In a significant milestone for the company, it raised $30 million through a Series A funding round that was spearheaded by ExSight Ventures along with a key corporate investor. This funding round also saw participation from Main Street Advisors and the University of California (UC Investments).
Advancement in Surgical Technology
The infusion of capital is set to catalyze the development of Horizon’s advanced technology platform, which aims to revolutionize the field of ophthalmic surgery. This platform, known as Polaris, leverages cutting-edge robotics, sophisticated medical imaging, and artificial intelligence to enhance surgical precision significantly. The company's commitment to advancing microsurgery is exemplified through its focus on automated AI-enabled robotics, which stretches the capabilities of surgeons to new heights.
Commitment to Innovation
With these funds, Horizon Surgical Systems will not only progress towards initiating first-in-human clinical studies but also expand its expert team. The journey towards integrating its innovative surgical robotics into routine procedures is expected to enhance the outcomes for patients while improving access to care. Horizon’s leadership envisions a future where robotic technology makes eye surgery more efficient and reliable.
Board Strengthening
In conjunction with the raising of funds, Horizon's board has seen the addition of two esteemed members: Firas M. Rahhal, M.D., who is a founder and general partner at ExSight Ventures, and William A. Link, PhD. Dr. Rahhal expressed his enthusiasm for joining the board, highlighting the great technological advancements anticipated with robotic cataract surgery and its potential to make surgeries faster with fewer complications.
Expert Contributions
Dr. William A. Link brings a wealth of experience from his prior roles, including founder and CEO at Chiron Vision, which was later sold to Bausch and Lomb. His insights into early-stage investments in biopharma and medical devices are poised to significantly contribute to Horizon’s growth. Both Dr. Rahhal and Dr. Michael Nissen, his co-founder at ExSight, foresee the Horizon technology as a transformative force in ophthalmic surgery.
Statement from Leadership
Jean-Pierre Hubschman, M.D., the founder and CEO of Horizon, expressed pride in the company’s progress and the strong support received from investors, which includes ExSight Ventures and other key stakeholders. Dr. Hubschman elaborated on how the Polaris system is equipped to redefine the surgical landscape, emphasizing the seamless integration of augmented visualization with robotic precision. The advancements expected through this technology are anticipated to enhance surgical accuracy and overall patient outcomes.
About Horizon Surgical Systems
Founded in 2021 as a spinoff from a prestigious research institution, Horizon Surgical Systems is dedicated to pushing the boundaries of microsurgery through innovative robotic technology. The company’s Polaris system stands out in the field due to its unique combination of state-of-the-art robotics, advanced imaging techniques, and AI-driven solutions aimed at advancing surgical precision. This dynamic approach not only empowers surgeons but represents a significant leap forward in surgical care.
Frequently Asked Questions
What is Horizon Surgical Systems?
Horizon Surgical Systems, Inc. is a micro-robotics company focused on enhancing microsurgical procedures through advanced robotic technology.
How much funding has Horizon Surgical Systems raised?
The company recently secured $30 million in Series A financing to fuel its development efforts.
Who led the funding round for Horizon?
The funding round was led by ExSight Ventures along with contributions from other notable investors.
What is the Polaris system?
Polaris is Horizon’s flagship product designed to utilize robotics and AI to improve surgical precision and outcomes in eye surgery.
What are the future plans for Horizon Surgical Systems?
Horizon plans to advance to first-in-human studies and continue its development in the field of surgical robotics.
About The Author
Contact Olivia Taylor privately here. Or send an email with ATTN: Olivia Taylor as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.